Successful acamprosate treatment of alcohol dependence in schizophrenia

Schizophrenia Research

Volumn 106, Issue 2-3, 2008, Pages 373-

  Tek, Cenk ^a   Srihari, Vinod ^a   Tek, Ece ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACAMPROSATE; GLUCOSE;

ADULT; ALCOHOL CONSUMPTION; ALCOHOLISM; BLOOD PRESSURE; CASE REPORT; DIABETES MELLITUS; ECHOGRAPHY; FATTY LIVER; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; LETTER; PRIORITY JOURNAL; SCHIZOPHRENIA;

AGED; ALCOHOL DETERRENTS; ALCOHOLISM; COMORBIDITY; FEMALE; HUMANS; SCHIZOPHRENIA; TAURINE; TREATMENT OUTCOME;

EID: 56049112779     PISSN: 09209964     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.schres.2008.08.010     Document Type: Letter

References (3)

1. Bouza C., Angeles M., Munoz A., and Amate J.M. Efficacy and safety of naltrexone and acamprosate in the treatment of alcohol dependence: a systematic review. Addiction 99 7 (2004) 811-828
2. Chick J., Howlett H., Morgan M.Y., and Ritson B. United Kingdom Multicentre Acamprosate Study (UKMAS): a 6-month prospective study of acamprosate versus placebo in preventing relapse after withdrawal from alcohol. Alcohol Alcohol. 35 2 (2000) 176-187
3. Regier D.A., Farmer M.E., Rae D.S., Locke B.Z., Keith S.J., Judd L.L., and Goodwin F.K. Comorbidity of mental disorders with alcohol and other drug abuse. Results from the Epidemiologic Catchment Area (ECA) Study. JAMA 264 19 (1990) 2511-2518